BioLineRx (BLRX) Depreciation & Amortization (CF) (2014 - 2026)
BioLineRx's Depreciation & Amortization (CF) came in at $78,000 for the quarter ended Jun 30, 2026, down 11.4% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported Depreciation & Amortization (CF) of $348,000, down 87.8% year-over-year; for the year ended Dec 31, 2025, it was $523,000, down 87.1% from the prior year.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -11.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Depreciation & Amortization (CF) was $4.07 million in the year ended Dec 31, 2024 (+193.7%), $1.38 million in the year ended Dec 31, 2023 (+111.6%), $654,000 in the year ended Dec 31, 2022 (-7.0%) and $703,000 in the year ended Dec 31, 2021 (-24.7%).
- The five-year range for quarterly Depreciation & Amortization (CF) is $63,000 (the quarter ended Dec 31, 2025) to $1.85 million (the quarter ended Dec 31, 2024).
- Year-over-year, Depreciation & Amortization (CF) increased in two of the last six quarters, with growth averaging 22.0%.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in the quarter ended Sep 30, 2024 (growth of 280.1%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 96.6%).
- Business Quant data shows BLRX's Depreciation & Amortization (CF) at $88,000 (quarter ended Mar 31, 2026), $63,000 (quarter ended Dec 31, 2025) and $119,000 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | 78,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 840,000.00 |
| Jun 30, 2024 | 482,000.00 |
| Mar 31, 2024 | 897,000.00 |
| Dec 31, 2023 | 706,000.00 |
| Sep 30, 2023 | 221,000.00 |
| Jun 30, 2023 | 198,000.00 |
| Mar 31, 2023 | 259,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 141,000.00 |
| Mar 31, 2022 | 173,000.00 |
| Dec 31, 2021 | 174,000.00 |
| Sep 30, 2021 | 167,000.00 |
| Jun 30, 2021 | 180,000.00 |
API Access
BioLineRx Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();